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DOPA uptake in SHR immortalized renal proximal tubular
cells.
Background. Spontaneously hypertensive rats (SHR) may
have an increased renal production of dopamine. LAT2 pro-
motes L-DOPA renal uptake, and this may determine the rate
of dopamine synthesis. The present study evaluated L-DOPA
inward and outward transfer in immortalized renal proximal
tubular epithelial cells of SHR and Wistar-Kyoto rats (WKY).
Methods. Uptake of [14C]-L-DOPA was initiated by the addi-
tion of 1 mL Hanks’ medium with a given concentration of the
substrate. The apical fractional outflow of intracellular [14C]-L-
DOPA was evaluated in cells loaded with [14C]-L-DOPA for
6 minutes, and then the corresponding efflux was monitored
over 12 minutes. The presence of LAT1 and LAT2 transcripts
and protein in WKY and SHR cells was examined, respectively,
by reverse transcription-polymerase chain reaction (RT-PCR)
and immunobloting.
Results. LAT2 in WKY cells contributed almost exclusively
for [14C]-L-DOPA uptake. In SHR cells [14C]-L-DOPA uptake
was 25% through system B0, 25% through LAT2 (resulting
from inhibition by 1 mmol/L glycine, L-alanine, L-serine, and
L-threonine), and the remaining 50% through LAT1. The ef-
flux of [14C]-L-DOPA from WKY and SHR cells corresponded
to ∼65% and ∼25%, respectively, of the amount accumulated
in the cells. The LAT1 and LAT2 transcripts were present in
both SHR and WKY cells, but the abundance of both LAT1
and LAT2 proteins in SHR cells was greater than in WKY cells.
Conclusion. Differences in L-DOPA handling between SHR
and WKY cells may result from over-expression of LAT1 and
LAT2 transporters in the former. The unique role of Na+-
dependent transporters (system B0) in SHR cells also con-
tributes to the enhanced L-DOPA uptake in these cells.
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The proximal tubules, but not distal segments of
the nephron, are endowed with a high aromatic L-
amino acid decarboxylase (AADC) activity, and epithe-
lial cells of proximal tubules have been demonstrated
to synthesize dopamine from circulating or filtered L-
3,4-dihydroxyphenylalanine (L-DOPA) [1–3]. Recently,
L-DOPA uptake in renal epithelial cells was suggested
to be promoted through the Na+-independent and pH-
sensitive type 2 L-type amino acid transporter (LAT2)
[4], the activity of which may rate limit the synthesis of
renal dopamine [5].
Dopamine of renal origin exerts natriuretic and di-
uretic effects by activating D1-like receptors located at
various regions in the nephron [6, 7]. At the level of the
proximal tubule, the overall increase in sodium excre-
tion produced by dopamine and D1 receptor agonists
results from inhibition of the main sodium transport
mechanisms at the basolateral and apical membranes,
Na+-K+-ATPase [2, 8] and Na+/H+ exchanger [9], re-
spectively. In the spontaneously hypertensive rat (SHR),
dopamine D1-like receptor-mediated natriuretic and di-
uretic responses are diminished under normal conditions,
as well as during acute volume expansion (5% body
weight), compared with those responses in normotensive
control Wistar-Kyoto rats (WKY) [7, 10, 11]. However,
dopamine production and excretion in SHR is normal or
even increased when compared with that in WKY [12–
14]. This would suggest that in SHR the increased ability
to form dopamine at the kidney level might correspond to
an attempt to overcome the deficient dopamine-mediated
natriuresis [7], as has been reported in aged Fischer 344
rats [15].
The hypothesis we have explored in the present study
concerns the occurrence of adaptations in renal L-DOPA
transporters in hypertension and its putative role in en-
hanced renal dopamine formation in genetic hyperten-
sion. For this purpose we measured the inward and
216
Pinho et al: Over-expression of renal LAT1 and LAT2 in hypertension 217
outward transfer of L-DOPA in immortalized renal prox-
imal tubular epithelial cells from WKY and SHR, and
evaluated the presence and expression of LAT1 and
LAT2 in these cells.
METHODS
Cell culture
Immortalized renal proximal tubular epithelial cells
from SHR and WKY animals were obtained from the
Department of Physiology, Case Western Reserve Med-
ical School, Cleveland, Ohio [16], and maintained in a
humidified atmosphere of 5% CO2-95% air at 37◦C.
SHR and WKY cells were grown in Dulbecco’s modi-
fied Eagle’s medium nutrient mixture F-12 Ham (Sigma
Chemical Company, St. Louis, MO, USA) supplemented
with 100 U/mL penicillin G, 0.25 lg/mL amphotericin B,
100 lg/mL streptomycin (Sigma), 5% fetal bovine serum
(Sigma), and 25 mmol/L N-2-hydroxyethylpiperazine-
N′−2-ethanosulfonic acid (HEPES; Sigma). For sub-
culturing, the cells were dissociated with 0.10%
trypsin-EDTA, split 1:4, and subcultured in Costar flasks
with 75- or 162-cm2 growth areas (Costar, Badhoeve-
dorp, The Netherlands). For uptake studies, the cells were
seeded in collagen treated 24-well plastic culture clusters
(internal diameter 16 mm; Costar) at a density of 40,000
cells per well, or onto collagen-treated 0.2-lm polycar-
bonate filter supports (internal diameter 12 mm; Tran-
swell, Costar) at a density 13,000 cells per well (2.0 ×
104 cells cm2). The cell medium was changed every 2 days,
and the cells reached confluence after 3 to 5 days of in-
cubation. For 24 hours before each experiment, the cells
were maintained in fetal bovine serum-free medium. Ex-
periments were generally performed 2 to 3 days after cells
reached confluence, and 6 to 8 days after the initial seed-
ing; each cm2 contained about 80 to 100 lg of cell pro-
tein. The transepithelial resistance (.cm2) on the day of
the experiment, as determined with an automatic voltage
current clamp (DVC 1000; World Precision Instruments,
Sarasota, FL, USA) was 12 ± 1 and 589 ± 98 in WKY
and SHR, respectively.
Inward transfer of L-DOPA
On the day of the experiment, the growth medium was
aspirated, and the cell monolayers were preincubated
for 30 minutes in Hanks’ medium at 37◦C. The Hanks’
medium had the following composition (mmol/L): NaCl
137, KCl 5, MgSO4 0.8, Na2HPO4 0.33, KH2PO4 0.44,
CaCl2 0.25, MgCl2 1.0, Tris HCl 0.15, and sodium bu-
tyrate 1.0, pH = 7.4. The incubation medium also con-
tained benserazide (30 lmol/L) and tolcapone (1 lmol/L)
in order to inhibit the enzymes AADC and catechol-
O-methyltransferase, respectively. Uptake was initiated
by the addition of 1 mL Hanks’ medium with a given
concentration of the substrate. Time course studies were
performed in experiments in which cells were incubated
with 0.25 lmol/L [14C]-L-DOPA for 1, 3, 6, 12, 30, and
60 minutes. Saturation experiments were performed in
cells incubated for 6 minutes with 0.25 lmol/L [14C]-
L-DOPA in the absence and in the presence of in-
creasing concentrations of the unlabeled substrate. In
experiments performed in the presence of different con-
centrations of sodium, sodium chloride was replaced by
an equimolar concentration of choline chloride. In inhibi-
tion studies, test substances were applied from the apical
side and were present during the incubation period only.
During preincubation and incubation, the cells were con-
tinuously shaken and maintained at 37◦C. Uptake was
terminated by the rapid removal of uptake solution by
means of a vacuum pump connected to a Pasteur pipette
followed by a rapid wash with cold Hanks’ medium and
the addition of 500 lL of 0.1% vol/vol Triton X-100 (dis-
solved in 5 mmol/L Tris HCl, pH 7.4). Radioactivity was
measured by liquid scintillation counting.
Outward transfer of L-DOPA
In cells cultured in plastic culture clusters the api-
cal fractional outflow of intracellular [14C]-L-DOPA was
evaluated in cells loaded with 2.5 lmol/L [14C]-L-DOPA
for 6 minutes, and then the corresponding efflux moni-
tored over 12 minutes in the absence and the presence of
different amino acids. In experiments designed to study
the efflux of L-DOPA through the apical and basal cell
sides, cells cultured in polycarbonate filters were loaded
for 6 minutes with 2.5 lmol/L [14C]-L-DOPA applied
from both cell sides. Thereafter, the cells were washed
in ice-cold Hanks’ medium. Outward transport of intra-
cellular [14C]-L-DOPA was initiated by adding warmed
(37◦C) Hanks’ medium to the apical and the basal side
of the monolayers. For the measurement of outward
transport, the medium in the apical and the basal side
was collected after incubation for the specified period of
time, and the radioactivity was counted. An aliquot of
the medium (50 lL in the apical side or 100 lL in the
basal side) was collected every 3 minutes over a period of
12 minutes, and the aliquot was replaced with an equal
volume of Hanks’ medium. The data at 6, 9, and 12 min-
utes represent cumulative values. The monolayers were
agitated every 3 minutes during transport measurement.
In some experiments, cell monolayers were incubated in
the presence of unlabeled L-DOPA (1 mmol/L) added
from the apical or the basal side. At the end of the
transport experiment, the medium was immediately aspi-
rated, and the filter was washed three times with ice-cold
Hanks’ medium. Subsequently, the cells were solubilized
by 0.1% v/v Triton X-100 (dissolved in 5 mmol/L Tris
HCl, pH 7.4), and radioactivity was measured by liquid
218 Pinho et al: Over-expression of renal LAT1 and LAT2 in hypertension
scintillation counting. Fractional outflow was calculated
using the expression
[14C]-L-DOPAfluid/([14C]-L-DOPAfluid
+ [14C]-L-DOPAcell)
where [14C]-L-DOPAfluid indicates the amount of radi-
olabeled L-DOPA (in pmol/mg protein) that reached
the fluid bathing the apical or basal cell side and
[14C]-L-DOPAcell (in pmol/mg protein) indicates the
amount of radiolabeled L-DOPA accumulated in the cell
monolayer.
Protein assay
The protein content of cell monolayers was determined
by the method of Bradford [17], with human serum albu-
min as a standard.
Cell viability
Cells were preincubated for 30 minutes at 37◦C and
then incubated in the absence or the presence of L-DOPA
and test compounds for another 6 minutes. Subsequently,
the cells were incubated at 37◦C for 2 minutes with Try-
pan blue (0.2% w/v) in phosphate buffer. Incubation was
stopped by rinsing the cells twice with Hanks’ medium,
and the cells were examined using a Leica microscope
(Wetzlar, Germany). Under these conditions, more than
95% of the cells excluded the dye.
RNA extraction
Tissues were homogenized (Diax, Heidolph) in Trizol
reagent (75 mg/mL) (Invitrogen, Carlsbad, CA, USA),
and total RNA was extracted according to manufac-
turer’s instructions. The RNA obtained was dissolved in
diethylpyrocarbonate (DEPC)-treated water and quan-
tified by spectrophotometry at 260 nm.
Reverse transcription (RT)-PCR
One microgram total RNA was reverse transcribed to
cDNA with SuperScript First Strand Synthesis System
for reverse transcription-polymerase chain reaction (RT-
PCR) (Invitrogen) according to manufacturer’s instruc-
tions. The reverse transcription was performed at 50◦C
using 5 lg/lL random hexamers.
The LAT1 cDNA was amplified by PCR using two
sets of primers: one specific for rat LAT1 (forward: 5′-
CAT CAT CGG TTC GGG CAT CTT-3′, and reverse:
5′-CAG GGT GAC AAT GGG CAA GGA-3′); another
simultaneously specific for human, rat, and mice LAT1
(forward: 5′-GG(C/T) TCG (G/T)GC ATC TTC GT-3′
and reverse: 5′-(G/A)CA (G/C)AG CCA GTT GAA
GAA GC-3′) corresponding to nucleotides 285 and 1267
of the human cDNA (GenBank accession AF104032).
The LAT2 cDNA was amplified by PCR using one
set of primers simultaneously specific for human, rat,
and mice LAT2 (forward: 5′-CA(C/G) CCG (A/G)AC
AAC ACC G(A/C)(A/C/G) AAG-3′ and reverse: 5′-
TGC CAG TA(A/G) ACA CCC AGG AA(A/G)-3′) cor-
responding to nucleotides 242 and 1612 of the human
cDNA (GenBank accession AF171669).
PCR was performed with Platinum TaqPCRx DNA
Polymerase (Invitrogen) with 1× enhancer (LAT1) or
without enhancer (LAT2). Amplification conditions were
as follows: hot start of 2 minutes at 95◦C; 30 cycles of
denaturing (95◦C for 30 seconds), annealing (58◦C for
30 seconds), and extension (68◦C for 45 seconds); and a
final extension of 7 minutes at 68◦C.
The PCR products were separated by electrophoresis
in a 2% agarose gel and visualized under UV light in the
presence of ethidium bromide.
Immunoblotting
Cell monolayers (WKY and SHR cells) were washed
with PBS and then lysed in RIPA buffer containing
150 mmol/L NaCl, 50 mmol/L Tris-HCl, pH 7.4, 5 mmol/L
EDTA, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, 100 lg/mL PMSF, 2 lg/mL leupeptin, and
2 lg/mL aprotinin. Protein concentration was determined
using a protein assay kit (Bio-Rad Laboratories, Her-
cules, CA, USA) with bovine serum albumin as standard.
Cell lysates were boiled in sample buffer (35 mmol/L
Tris-HCl, pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01%
bromophenol blue, 30% glycerol) at 95◦C for 5 min-
utes. Samples containing 40 lg of cell protein were sep-
arated by SDS-PAGE with 10% polyacrylamide gel, and
then electroblotted onto nitrocellulose membranes (Bio-
Rad). Blots were blocked overnight with 5% nonfat dry
milk in PBS-T (0.05% Tween 20 in 10 mmol/L phosphate-
buffered saline) at 4◦C with constant shaking. Blots were
then incubated with rabbit anti-LAT1 polyclonal anti-
body (1:500; Serotec, Oxford, UK) and rabbit antimouse
LAT2 polyclonal antibody [18] (1:2000; kindly provided
by Prof. Franc¸ois Verrey) in 5% nonfat dry milk in TBS-
T for 1.5 hours at room temperature. Membranes were
washed three times with TBS-T and then incubated with
peroxidase-labeled goat antirabbit IgG (1:3000; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) for 1.5 hours
at room temperature and developed for detection of
the specific protein using enhanced chemiluminescence
reagents (Amersham, Little Chalfont, UK).
Drugs
L- and D-amino acids, 2-aminobicyclo (2,2,1)-heptane-
2-carboxylic acid (BCH), benserazide, N-(methylamino)-
isobutyric acid, and Trypan blue were purchased from
Sigma Chemical Company, St. Louis, Mo, USA. Tol-
capone was kindly donated by the late Professor Mose´ Da
Prada (Hoffman La Roche, Basel, Switzerland). [14C]-L-
DOPA specific activity 51 mCi/mmol was purchased from
Amersham Pharmacia Biotech.
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Fig. 1. (A) Time course of [14C]-L-DOPA (0.25 lmol/L) uptake in
WKY and SHR cells; the inset shows the time-dependent L-DOPA
accumulation in WKY cells. (B) Effect of increasing concentrations of
L-DOPA (3, 10, 30, 100, and 300 lmol/L) on the uptake of [14C]-L-
DOPA (2.5 lmol/L) in WKY and SHR cells. Symbols represent the
mean of 4 to 8 experiments per group; vertical lines show SEM. WKY,
Wistar-Kyoto; SHR, spontaneously hypertensive rats.
Data analysis
Km and Vmax values for the uptake of [14C]-L-DOPA,
as determined from a competitive uptake inhibition pro-
tocol [19], were calculated from nonlinear regression
analysis using the GraphPad Prism statistics software
package (San Diego, CA, USA) [20]. Arithmetic means
are given with SEM. Statistical analysis was performed
by one-way analysis of variance (ANOVA) followed
by Newman-Keuls test for multiple comparisons. A P
value less than 0.05 was assumed to denote a significant
difference.
RESULTS
Inward transfer of L-DOPA
In both cell types, uptake of a nonsaturating concen-
tration of [14C]-L-DOPA (0.25 lmol/L) was linear with
Table 1. Km (lmol/L) and Vmax (pmol/mg protein/6 min) values for
the saturable component of [14C]-L-DOPA uptake in cultured WKY
and SHR cells
[14C]-L-DOPA
Km Vmax
WKY 29 ± 3 10836 ± 1076
SHR 111 ± 16a 22183 ± 4349a
Values are mean ± SEM of 6 experiments per group.
aP < 0.05 is significantly different from WKY cells.
time for up to 12 minutes of incubation (Fig. 1A). At
6 minutes, when uptake was linear and considering intra-
cellular water as 7.0 ± 0.7 lL/mg protein [21], the cellular
[14C]-L-DOPA concentrations were 13.2 ± 0.9 lmol/L
and 5.3 ± 0.5 lmol/L in SHR and WKY cells, respec-
tively. This represented an intracellular concentration of
[14C]-L-DOPA that was 26.4 ± 1.9 and 10.6 ± 1.0 times
higher than the corresponding medium concentration.
In order to determine the kinetics of the transporters,
cells were incubated for 6 minutes with [14C]-L-DOPA
(0.25 lmol/L) in the absence or in presence of increas-
ing concentrations of unlabeled substrate L-DOPA (3
to 300 lmol/L) (Fig. 1B). The uptake of the substrate
was reduced in the presence of unlabeled L-DOPA in a
concentration-dependent manner. Kinetic parameters of
[14C]-L-DOPA uptake (Km and Vmax) were determined
by nonlinear analysis of the specific analysis of inhibition
curve for L-DOPA and are given in Table 1. As shown
in the Table, the affinity of the transporter for L-DOPA
in WKY cells was thrice that in SHR cells, as evidenced
by differences in Km values. Substrate selectivity of L-
DOPA uptake was investigated by inhibition experiments
in which 0.25-lmol/L [14C]-L-DOPA uptake was mea-
sured in the presence of 1 mmol/L of unlabeled amino
acids (Fig. 2). As shown in Figure 2, in WKY cells the
uptake of L-DOPA was inhibited by glycine and the L-
isomers of neutral amino acids and histidine. Proline, the
acidic amino acids aspartate and glutamate, and the basic
amino acid arginine, lysine, and cystine did not inhibit
L-DOPA uptake in WKY cells. The profile of inhibi-
tion in SHR cells differed considerably from that ob-
served in WKY cells, namely the sensitivity of L-DOPA
uptake to inhibition by small neutral amino acids ala-
nine, serine, and threonine; asparagine and glutamine
were also ineffective in reducing [14C]-L-DOPA accu-
mulation. Another difference between WKY and SHR
cells concerned the sensitivity of [14C]-L-DOPA uptake
to inhibition by D- and L-isomers. In SHR cells D-DOPA
did not affect the accumulation of [14C]-L-DOPA uptake,
whereas in WKY cells D-DOPA produced marked inhi-
bition of [14C]-L-DOPA accumulation (Fig. 3). All the
experiments mentioned above were performed in the
presence of 140 mmol/L Na+ in the uptake solution. Be-
cause amino acid transport across plasma membranes
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Fig. 2. Effect of glycine (1 mmol/L) and the
indicated L-amino acids (1 mmol/L) on the
uptake of [14C]-L-DOPA (0.25 lmol/L) in
WKY and SHR cells. Columns represent the
mean of 4 experiments per group; vertical
lines show SEM.
can be mediated by both Na+-dependent and Na+-
independent transporters, NaCl was replaced by an
equimolar concentration of choline chloride in order
to determine a potential Na+ dependency in [14C]-L-
DOPA apical inward. As show in Figure 4A, the effect
of removing Na+ from the uptake solution produced
a slight, but statistically significant (P < 0.05) reduc-
tion of [14C]-L-DOPA uptake in SHR cells, but did
not alter [14C]-L-DOPA transport in WKY cells. Alto-
gether, these results indicate that transport of L-DOPA
in both types of cells may be promoted through the
L-type amino acid transporter. In order to confirm
this hypothesis, the next series of experiments was
addressed to study the effect of the amino acid
analogs N-(methylamino)-isobutyric acid (MeAIB) and
2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid (BCH),
inhibitors of the A- and L-type amino acid transporters,
respectively. As depicted in Figure 4B, BCH but not
MeAIB produced a marked decrease in [14C]-L-DOPA
accumulation in both types of cells. These results sug-
gest that the inward transfer of [14C]-L-DOPA in both
WKY and SHR cells may be largely promoted through
the BCH-sensitive and Na+-independent L-type amino
acid transporter.
The effect of pH on [14C]-L-DOPA influx was exam-
ined by changing the pH of the uptake solution. As shown
in Figure 5, [14C]-L-DOPA accumulation in WKY and
SHR cells was greater at an acidic pH. In fact, the pH-
sensitive L-DOPA uptake in WKY and SHR cells was
33.4 ± 2.7 and 31.8 ± 2.3 pmol/mg protein/pH unit, re-
spectively.
Outward transfer of L-DOPA
Because some amino acid transporters have been
shown to function as amino acid exchangers, another se-
ries of experiments was conducted in cells loaded with
[14C]-L-DOPA for 6 minutes, and then the correspond-
ing efflux monitored over 12 minutes in the absence and in
presence of unlabeled L-DOPA. As shown in Figure 6B,
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Fig. 3. Effect of L-DOPA (1 mmol/L) and D-DOPA (1 mmol/L) on
the uptake of [14C]-L-DOPA (0.25 lmol/L) in WKY and SHR cells.
Columns represent the mean of 8 experiments per group; vertical lines
show SEM. Significantly different from corresponding control values.
∗P < 0.05.
the efflux of [14C]-L-DOPA from SHR cells over 12 min-
utes corresponded to approximately 25% of the amount
of [14C]-L-DOPA accumulated in the cells (i.e., SHR
cells were able to retain most of the taken up substrate)
(Fig. 6A). In contrast, [14C]-L-DOPA efflux was higher in
WKY cells with values of ∼65% of the amount accumu-
lated in the cells (Fig. 6C). Adding unlabeled L-DOPA
to the extracellular medium markedly increased the
efflux of [14C]-L-DOPA in both cell types (Fig. 7A). By
contrast, D-DOPA failed to stimulate the efflux of [14C]-
L-DOPA in both WKY and SHR cells (Fig. 7B). This is
in agreement with the view that the L-DOPA transporter
functions as an exchanger, and there is stereoselectiv-
ity in the exchange process. However, the potency of L-
DOPA stimulated [14C]-L-DOPA efflux in WKY [EC50 =
35 (18, 70) lmol/L; mean and 95% CI, respectively] was
greater than in SHR cells [EC50 = 394 (144, 1079) lmol/L,
respectively].
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In experiments designed to study the efflux of L-DOPA
through the apical and basal cell sides, cells cultured
in polycarbonate filters were loaded for 6 minutes with
2.5 lmol/L [14C]-L-DOPA applied from both cell sides.
For the measurement of apical and basal [14C]-L-DOPA
efflux, the cells cultured in polycarbonate filters were
incubated for 12 minutes with Hanks’ medium in the
absence and the presence of unlabeled L-DOPA (1
mmol/L). The spontaneous apical fractional outflow (%)
of [14C]-L-DOPA in WKY cells was similar to that
through the basal cell side (Fig. 8A). The addition of
nonlabeled L-DOPA from the apical or basal cell side re-
sulted in similar increases on the apical and basal efflux of
[14C]-L-DOPA (Fig. 8A). In SHR cells the spontaneous
fractional outflow of [14C]-L-DOPA from the apical or
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Fig. 5. Effect of pH on the uptake of [14C]-L-DOPA (0.25 lmol/L) in
WKY and SHR cells. Symbols represent the mean of 8 experiments per
group; vertical lines show SEM.
basal cell side was considerably lower than that in WKY
cells. Another difference between WKY and SHR cells
was that in SHR cells L-DOPA significantly increased the
fractional outflow of [14C]-L-DOPA from the basal cell
side only (Fig. 8B).
Detection of LAT1 and LAT2 transcripts
The expression of LAT1 and LAT2 in SHR and WKY
cells was examined by RT-PCR using specific primers for
either LAT1 or LAT2 rat cDNAs. As shown in Figure 9,
the expected 688-bp fragment corresponding to LAT1
and the LAT2 1391-bp fragment were present in both
SHR and WKY cells.
Expression of LAT1 and LAT2
The presence of LAT1 and LAT2 protein in SHR and
WKY cells was studied by means of immunoblotting us-
ing antibodies raised against the rat LAT1 and mouse
LAT2. As shown in Figure 10, antibodies against LAT1
and LAT2 recognized the presence of LAT1 and LAT2
in both WKY and SHR cells. In agreement with the func-
tional data, the abundance of LAT1 was greater in SHR
cells than in WKY cells.
DISCUSSION
In the present study we showed that immortalized
WKY and SHR renal tubular epithelial cells transport
L-DOPA quite efficiently through the apical cell border,
and several findings demonstrate that this uptake process
is a facilitated mechanism. Though most of [14C]-L-
DOPA was entering the cells in a Na+-independent
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manner, a minor component of [14C]-L-DOPA uptake
(∼25%) in SHR cells was found to require extracellular
Na+. [14C]-L-DOPA uptake in WKY and SHR cells was
sensitive to inhibition by BCH, but not to MeAIB, and
sensitive to inhibition by neutral, but insensitive to acidic
and basic amino acids. In addition, [14C]-L-DOPA uptake
in WKY and SHR cells shows trans-stimulation by unla-
beled L-DOPA. Taken together, these findings agree with
the view that L-DOPA may be transported by systems
B0 (Na+-dependent) and L (Na+-independent) in SHR
cells, whereas in WKY cells L-DOPA may be transported
through system L only. In agreement with the functional
data, the abundance of both LAT1 and LAT2 in SHR
cells was greater than in WKY cells.
The sensitivity of [14C]-L-DOPA uptake to BCH, but
not to MeAIB, supports the view that inward transfer
in WKY and SHR cells is promoted neither by the A-
nor the ASC-type amino acid transporter. System B0 is
a broad-specificity amino acid transport system cotrans-
porting neutral amino acids with Na+ into cells that also
accept BCH but not MeAIB [22]. System B0,+ is also a
Na+-dependent transporter that has a broad-specificity
for zwitterionic and basic amino acids, and also accepts
BCH, but not MeAIB [22]. The uptake of [14C]-L-DOPA
was inhibited by neutral amino acids such as phenylala-
nine, leucine, and tyrosine, and blocked by BCH, but not
by MeAIB and the acidic and basic amino acids. For this
reason it is likely that system B0 rather than system B0,+
might be responsible for the Na+-dependent uptake of
[14C]-L-DOPA in SHR cells. This Na+-dependent trans-
porter of L-DOPA may correspond to that responsible for
Na+-dependent and ouabain-sensitive L-DOPA trans-
porter previously identified in rat and human renal cortex
[23, 24]. A minor Na+-dependent component of L-DOPA
uptake has also been identified in several renal epithelial
cell lines [4, 25].
Other candidate transport systems for L-DOPA may
include the Na+-independent systems L (LAT1 and
LAT2) and b0,+. Both b0,+ and LAT1 were found to
transport L-DOPA, the former in Xenopus laevis oocytes
injected with poly A+ RNA prepared from rabbit intesti-
nal epithelium [26], and the latter in mouse brain cap-
illary endothelial cells [27]. In agreement with the view
that LAT2 may play a role in L-DOPA transport is the
recent observation that in opossum kidney (OK) renal
tubular cells, L-DOPA uses at least two major trans-
porters, systems LAT2 and b0,+ [4]. The transport of
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 6. (A) Intracellular levels, (B) efflux, and (C) fractional outflow
of [14C]-L-DOPA in WKY and SHR cells. Cells were incubated for
6 minutes in the presence 2.5 lmol/L [14C]-L-DOPA and then incubated
for 1, 3, 6, and 12 minutes. Symbols represent the mean of 8 experiments
per group; vertical lines show SEM. Significantly different from control
values (∗P < 0.05).
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Fig. 7. Fractional outflow (%) of [14C]-L-DOPA in WKY and SHR
cells in the absence and in the presence of (A) unlabeled L-DOPA
and (B) unlabeled D-DOPA. Cells were incubated for 6 minutes in
the presence of 2.5 lmol/L [14C]-L-DOPA and then incubated in the
absence and the presence of increasing concentrations of unlabeled L-
DOPA and D-DOPA for 6 minutes. Symbols represent the mean of 8
experiments per group; vertical lines show SEM.
L-DOPA by LAT2 corresponds to a Na+-independent
transporter with a broad specificity for small and large
neutral amino acids, stimulated by acid pH, and inhib-
ited by BCH [4, 28]. The transport of L-DOPA by sys-
tem b0,+ is a Na+-independent transporter for neutral
and basic amino acids that also recognizes the diamino
acid cystine [4]. Major differences between LAT1 and
LAT2 are concerned with amino acid specificity and affin-
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Fig. 8. Basal-to-apical (B-A) and apical-to-basal (A-B) spontaneous
and L-DOPA-stimulated fractional outflow of [14C]-L-DOPA in (A)
WKY and (B) SHR cells. Cells were incubated for 6 minutes in the
presence of 2.5 lmol/L [14C]-L-DOPA, and then incubated in the ab-
sence (Veh) and the presence of unlabeled L-DOPA (1 mmol/L) for
12 minutes. Symbols represent the mean of 4 experiments per group;
vertical lines show SEM. Significantly different from corresponding con-
trol values (∗P < 0.05).
ity. In fact, the affinity of LAT1 for large neutral amino
acids is higher than that for LAT2. LAT2 also transports
small neutral amino acids such as glycine, L-alanine, L-
serine, L-cysteine [29], whereas LAT1 has a low affinity
for these amino acids [30]. Another difference between
LAT1 and LAT2 is that the affinity of LAT2 for the trans-
port of asparagine and glutamine is greater than that for
LAT1. The LAT1 isoform is characterized for being pH
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Fig. 9. Detection of (A) LAT1 and (B) LAT2 in total RNA extracted
from WKY and SHR cells using LAT1 and LAT2 rat specific primers.
insensitive [31, 32], whereas LAT2 is pH sensitive [4, 28,
29]. Considering these characteristics, it is suggested that
transport of [14C]-L-DOPA in WKY cells occurs mainly
through LAT2 (Na+-independent, enhanced sensitivity
to inhibition by small neutral amino acids and asparagine
and glutamine, and pH sensitive). By contrast, transport
of [14C]-L-DOPA in SHR cells is suggested to occur at
least through LAT1 (reduced sensitivity to inhibition by
glycine, alanine, serine, and threonine, and reduced sen-
sitivity to inhibition by small neutral amino acids and as-
paragine and glutamine) and LAT2 (Na+-independent
and pH sensitive). The finding that accumulation of [14C]-
L-DOPA in WKY and SHR cells was significantly higher
at an acidic pH fits well with the view that L-DOPA up-
take in these cells is promoted through LAT2. A three-
fold difference in Km values for L-DOPA between WKY
and SHR cells might not be drastically important to allow
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Fig. 10. Abundance of (A) LAT1 and (B) LAT2 in WKY and SHR
cells. Each lane contains equal amount of protein (40 lg). Western
blots were repeated 4 to 6 times. Columns indicate relative density and
represent the mean of 4 to 6 separate experiments; vertical lines indicate
SEM. Significantly different from values for WKY cells. ∗P < 0.05.
differentiation between LAT1 and LAT2. In fact, the dif-
ference in affinity for LAT1 and LAT2 is usually a 10-fold
difference [30].
Though LAT2 in WKY cells appears to contribute al-
most exclusively for L-DOPA uptake, in SHR cells L-
DOPA uptake is 25% through system B0, 25% through
LAT2 (resulting from inhibition by 1 mmol/L glycine, L-
alanine, L-serine, and L-threonine), and the remaining
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50% through LAT1. Considering the arguments dis-
cussed above, and the fact that initial rate of uptake
(6-minute incubation) of [14C]-L-DOPA at nonsaturating
concentrations (0.25 lmol/L) by SHR (101 ± 7 pmol/mg
protein) was greater than that by WKY cells (33 ±
3 pmol/mg protein), then the amount of [14C]-L-DOPA
transported by LAT1, LAT2, and system B0 in SHR
would be 50, 25, and 25 pmol/mg protein, respectively,
whereas in WKY cells LAT2 would be responsible for
the transport of 33 pmol/mg protein, which is equiva-
lent to that in SHR cells. The results presented here also
show that WKY and SHR cells are endowed with tran-
scripts for both LAT1 and LAT2, and antibodies against
LAT1 and LAT2 recognized the presence of LAT1 and
LAT2 in both WKY and SHR cells. The data obtained
clearly show that SHR cells over-express the LAT1 and
LAT2 transporters, which correlates positively with the
increased ability of SHR cells to take up L-DOPA when
compared with WKY cells.
The results of [14C]-L-DOPA efflux studies in WKY
and SHR cells are also quite valuable to define the na-
ture of transporters involved in the handling of the sub-
strate. As most of the [14C]-L-DOPA did not leak out
of the cells during the 12-minute incubation in amino
acid free medium, the presence of an L-DOPA–induced
[14C]-L-DOPA efflux suggests that the L-DOPA trans-
porters function as exchangers. Both systems LAT1 and
LAT2 function as exchangers [18, 29, 33], and several
findings suggest that either transporter may participate in
[14C]-L-DOPA outward in exchange with the unlabeled
L-DOPA. In fact, the outward transfer of amino acids is
considerably greater through LAT2 than through LAT1
[29]. In this respect, it is interesting to underline the ob-
servation that the spontaneous [14C]-L-DOPA outward
transfer in WKY cells was considerably higher than in
SHR cells. Accordingly, the exchanger involved in the
outward transfer of [14C]-L-DOPA in WKY cells is sug-
gested to be the LAT2 transporter, whereas in SHR cells,
both LAT1 and LAT2 would promote the exchange of
[14C]-L-DOPA. It should be underlined that the affin-
ity of the [14C]-L-DOPA outward transporter in WKY is
greater than that in SHR, as evidenced by the rightward
shift of the L-DOPA–induced concentration-response
curve for [14C]-L-DOPA outward transfer. These find-
ings agree with those on the inward transport of [14C]-
L-DOPA. Though the majority of studies reported here
were performed in cells plated on plastic supports, some
experiments were carried out in cells cultured in polycar-
bonate filters with access to both the apical and basal cell
sides. The finding that increases in the fractional outflow
of [14C]-L-DOPA by L-DOPA were identical at both cell
sides suggests that LAT2 in WKY cells may be present
in both the apical and basolateral membranes. On the
other hand, in SHR, increases in the fractional outflow of
[14C]-L-DOPA by L-DOPA were particularly evident at
the basal cell side, suggesting that distribution of LAT1
and LAT2 might be polarized at the basal cell side. This
is a potential point of conflict because LAT1 and LAT2
have been suggested to have a basolateral location to fa-
cilitate absorption [30]. While in the rat kidney LAT2
has been shown to have a basolateral location [18], as
the present data suggest for WKY cells, LAT2 may also
show an apical location in cultured renal epithelial cells.
Similar findings were observed in opossum kidney cells
cultured in polycarbonate filters [4]. However, the apical
location of LAT2 in cultured renal epithelial cells is not
necessarily derived from the culture conditions used, as
the maintenance of SHR and WKY cells were exactly the
same.
From a conceptual point of view, the present study adds
new evidence in three important sectors. First, it reveals
the functional characteristics of the mechanisms govern-
ing the availability of dopamine’s precursor, L-DOPA, at
the renal level, where the amine plays the role of a lo-
cal hormone regulating Na+ absorption. Second, while
showing that Na+ may be not important for the uptake
of L-DOPA, it suggests that the increased renal synthe-
sis of dopamine after a high salt intake may depend on
the facilitation or stimulation of mechanisms promoting
the conversion of L-DOPA to dopamine [1–3, 34], rather
than stimulating the cellular uptake of L-DOPA. Finally,
because dopamine production and excretion in SHR is
normal or even increased when compared with that in
WKY [12–14], the enhanced tubular uptake of L-DOPA
and the over-expression of LAT1 and LAT2 in the SHR
might correspond to an attempt to overcome the defi-
cient dopamine-mediated natriuresis [7, 10, 11]. Whether
the findings described here in immortalized WKY and
SHR cells might translate to that occurring in WKY and
SHR animals is still being evaluated. However, recently
our group described that over-expression of LAT2 in the
SHR kidney may contribute to the enhanced L-DOPA
uptake, and this is organ specific and precedes the onset
of hypertension [35].
CONCLUSION
The inward transfer of L-DOPA in WKY and SHR
was a saturable process, being higher in the latter than
the former, whereas the outward transfer of L-DOPA
in WKY cells was greater than that in SHR cells. This
may explain why SHR cells retain large amounts of L-
DOPA in the intracellular compartment. It is suggested
that over-expression of LAT1 and LAT2 in SHR cells
may contribute to the enhanced L-DOPA uptake.
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